Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study

Journal of Clinical Pathology
Matti PukkilaV M Kosma

Abstract

To study the expression of versican, a large proteoglycan involved in repressing adhesion between cells and the extracellular matrix in pharyngeal squamous cell carcinoma (PSCC), and its relation to the expression of p53 and catenins, histological differentiation, clinical data, and prognosis. For the retrospective survey, primary tumours for analyses were obtained from 118 patients diagnosed with PSCC of the oropharynx or hypopharynx. The immunohistochemical expression of versican was studied and was related to the expression pattern of p53 and catenins, in addition to clinical data and survival. In the primary tumours, strong stromal versican expression was graded as low in 59 (50%) and high in 59 (50%) cases. In addition, intracellular versican staining was seen in nine (8%) tumours. In local lymph node metastases, strong stromal versican staining was significantly more frequent compared with the primary tumours (p = 0.018). Strong stromal versican staining was more frequently seen in less advanced tumours (p = 0.015). There was no association between versican expression and the other investigated variables (p53, catenins, TNM status, and histological grade). Neither stromal nor intracellular versican expression predicted ov...Continue Reading

References

Apr 1, 1996·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·B Bode-LesniewskaD R Zimmermann
May 1, 1996·Journal of Neuropathology and Experimental Neurology·W PaulusD R Zimmermann
Jun 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J BlackD M Parkin
Aug 8, 1998·The Journal of Biological Chemistry·Y ZhangB B Yang
Feb 18, 1999·Journal of Cellular Biochemistry·B L YangB B Yang
Mar 10, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F Berrino, G Gatta
Jun 22, 1999·Journal of Neuropathology and Experimental Neurology·L C AngB B Yang
Jan 16, 2002·Current Opinion in Oncology·Jill Bargonetti, James J Manfredi
Feb 13, 2002·The American Journal of Pathology·Malika TouabAnna Bassols
May 15, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M W M van den BrekelA J M Balm
Sep 17, 2002·Current Opinion in Cell Biology·Thomas N Wight
Nov 20, 2002·Proceedings of the National Academy of Sciences of the United States of America·Heejei YoonNatalia S Pellegata
Jan 18, 2003·The International Journal of Biochemistry & Cell Biology·Achilleas D TheocharisDimitrios A Theocharis
Jan 22, 2003·The British Journal of Dermatology·S KarvinenR Tammi
Apr 25, 2003·American Journal of Clinical Pathology·Malika TouabAnna Bassols
Sep 25, 2003·International Journal of Cancer. Journal International Du Cancer·Kirsi VoutilainenVeli-Matti Kosma

❮ Previous
Next ❯

Citations

Jan 23, 2009·Cancer Metastasis Reviews·Carmela RicciardelliDavid J Horsfall
Dec 15, 2010·Clinical & Experimental Metastasis·Miranda P WeenCarmela Ricciardelli
Aug 30, 2003·Surgical Oncology·Dorry L SegevMartha A Zeiger
May 20, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Yvonne Hui-Fang TengGeorge Wai-Cheong Yip
Aug 24, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Arko GorterEkaterina S Jordanova
May 30, 2006·Journal of Clinical Pathology·Matti PukkilaVeli-Matti Kosma
Jan 24, 2012·Breast Cancer Research : BCR·Bhuvanesh DaveJenny C Chang
Mar 4, 2014·The Veterinary Journal·Karine A DamascenoGeovanni D Cassali
Oct 4, 2011·Cellular and Molecular Life Sciences : CMLS·Elena GarusiRoberto Perris
Apr 21, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J KodamaY Hiramatsu
Jun 15, 2011·International Journal of Cancer. Journal International Du Cancer·Junji WasaNaoki Ishiguro
Jul 25, 2006·Molecular & Cellular Proteomics : MCP·Vincent CastronovoDario Neri
Jan 13, 2016·World Journal of Gastroenterology : WJG·Kornélia BaghyIlona Kovalszky
Jul 7, 2020·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Athanasios PapadasFotis Asimakopoulos
Oct 27, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J KodamaY Hiramatsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.